The deal was a massive win for Trillium shareholders; the purchase price of $18.50 per share was triple the stock's closing price just days before the announcement. 2. The Sci-Fi "Story": Jeff Lemire's Trillium
In August 2021, pharmaceutical giant announced its intent to buy Trillium Therapeutics for approximately $2.26 billion . buy trillium
The "story" behind this deal began decades earlier at University Health Network (UHN) and SickKids in Toronto. Researchers discovered a "do not eat me" signal (CD47) that cancer cells use to hide from the immune system. The deal was a massive win for Trillium
The deal was a massive win for Trillium shareholders; the purchase price of $18.50 per share was triple the stock's closing price just days before the announcement. 2. The Sci-Fi "Story": Jeff Lemire's Trillium
In August 2021, pharmaceutical giant announced its intent to buy Trillium Therapeutics for approximately $2.26 billion .
The "story" behind this deal began decades earlier at University Health Network (UHN) and SickKids in Toronto. Researchers discovered a "do not eat me" signal (CD47) that cancer cells use to hide from the immune system.